Harmony Biosciences Holdings Inc (HRMY)
33.43
+0.39
(+1.18%)
USD |
NASDAQ |
Nov 05, 16:00
33.00
-0.43
(-1.29%)
After-Hours: 18:13
Harmony Biosciences Holdings Price to Book Value: 3.195 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.157 |
| November 01, 2024 | 3.161 |
| October 31, 2024 | 3.070 |
| October 30, 2024 | 3.23 |
| October 29, 2024 | 3.965 |
| October 28, 2024 | 3.416 |
| October 25, 2024 | 3.297 |
| October 24, 2024 | 3.254 |
| October 23, 2024 | 3.254 |
| October 22, 2024 | 3.331 |
| October 21, 2024 | 3.340 |
| October 18, 2024 | 3.384 |
| October 17, 2024 | 3.342 |
| October 16, 2024 | 3.329 |
| October 15, 2024 | 3.392 |
| October 14, 2024 | 3.390 |
| October 11, 2024 | 3.328 |
| October 10, 2024 | 3.326 |
| October 09, 2024 | 3.211 |
| October 08, 2024 | 3.321 |
| October 07, 2024 | 3.285 |
| October 04, 2024 | 3.306 |
| October 03, 2024 | 3.323 |
| October 02, 2024 | 3.399 |
| October 01, 2024 | 3.750 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.822 |
| September 27, 2024 | 4.129 |
| September 26, 2024 | 4.199 |
| September 25, 2024 | 3.935 |
| September 24, 2024 | 3.991 |
| September 23, 2024 | 4.036 |
| September 20, 2024 | 4.146 |
| September 19, 2024 | 4.114 |
| September 18, 2024 | 4.046 |
| September 17, 2024 | 4.096 |
| September 16, 2024 | 4.090 |
| September 13, 2024 | 4.106 |
| September 12, 2024 | 3.985 |
| September 11, 2024 | 3.934 |
| September 10, 2024 | 3.962 |
| September 09, 2024 | 3.893 |
| September 06, 2024 | 3.756 |
| September 05, 2024 | 3.752 |
| September 04, 2024 | 3.803 |
| September 03, 2024 | 3.836 |
| August 30, 2024 | 3.797 |
| August 29, 2024 | 3.773 |
| August 28, 2024 | 3.742 |
| August 27, 2024 | 3.759 |
| August 26, 2024 | 3.815 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.336
Minimum
Oct 27 2023
30.89
Maximum
Nov 10 2020
10.26
Average
10.09
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 3.108 |
| EyePoint Pharmaceuticals Inc | 2.722 |
| Cassava Sciences Inc | 6.073 |
| Capricor Therapeutics Inc | 52.16 |
| Anavex Life Sciences Corp | 5.021 |
Price to Book Value Related Metrics
| PE Ratio | 15.84 |
| PS Ratio | 2.844 |
| Price to Free Cash Flow | 8.808 |
| Price | 33.43 |
| Earnings Yield | 6.31% |
| Market Cap | 1.907B |
| Operating PE Ratio | 11.06 |
| Normalized PE Ratio | 15.84 |